Overview Mesalamine 4 gm/60 mL Rectal Enema Status: Completed Trial end date: 2003-06-01 Target enrollment: Participant gender: Summary The objective of this study is to evaluate the relative bioavailability of the test formulation of mesalamine suspension rectal enema with the already marketed reference formulation Rowasa® in healthy, adult subjects. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Mesalamine